Specific detection of dengue and Zika virus antibodies using envelope proteins with mutations in the conserved fusion loop

References

• Gubler D, Kuno G, Markoff L.Flaviviruses.In:. Field’s Virology 2007 pp 1153–1252.
   Google Scholar
• Heinz FX, Stiasny K.The antigenic structure of Zika virus and its relation to other flaviviruses: implications for infection and immunoprophylaxis. Microbiol Mol Biol Rev 2017;81: e00055–16.
   PubMed Web of Science ®Google Scholar
• Bhatt S, Gething PW, Brady OJet al.The global distribution and burden of dengue. Nature 2013;496: 504–507.
   PubMed Web of Science ®Google Scholar
• Vannice KS, Durbin A, Hombach J.Status of vaccine research and development of vaccines for dengue. Vaccine 2016;34: 2934–2938.
   PubMed Web of Science ®Google Scholar
• Guy B, Jackson N.Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nat Rev Microbiol 2016;14: 45–54.
   PubMed Web of Science ®Google Scholar
• Lazear HM, Diamond MS.Zika virus: new clinical syndromes and its emergence in the western hemisphere. J Virol 2016;90: 4864–4875.
   PubMed Web of Science ®Google Scholar
• Lanciotti RS, Kosoy OL, Laven JJet al.Genetic and serologic properties of Zika virus associated with an epidemic, Yap State, Micronesia, 2007. Emerg Infect Dis 2008;14: 1232–1239.
   PubMed Web of Science ®Google Scholar
• Barzon L, Trevisan M, Sinigaglia Aet al.Zika virus: From pathogenesis to disease control. FEMS Microbiol Lett 2016;363: 1–17.
   Web of Science ®Google Scholar
• Pessôa R, Patriota JV, Lourdes de Souza Mdeet al.Investigation into an outbreak of dengue-like illness in Pernambuco, Brazil, revealed a cocirculation of Zika, chikungunya, and dengue virus type 1. Medicine (Baltimore) 2016;95: e3201.
   PubMed Web of Science ®Google Scholar
• Rabe IB, Staples JE, Villanueva Jet al.Interim guidance for interpretation of Zika virus antibody test results. MMWR Morb Mortal Wkly Rep 2016;65: 543–546.
   PubMed Web of Science ®Google Scholar
• Tang KF, Ooi EE.Diagnosis of dengue: an update. Expert Rev Anti Infect Ther 2012;10: 895–907.
   PubMed Web of Science ®Google Scholar
• Barzon L, Pacenti M, Ulbert Set al.Latest developments and challenges in the diagnosis of human West Nile virus infection. Expert Rev Anti Infect Ther 2015;13: 327–342.
   PubMed Web of Science ®Google Scholar
• Charrel RN, Leparc-Goffart I, Pas Set al.Background review for diagnostic test development for Zika virus infection. Bull World Health Organ 2016;94: 574–584D.
   PubMed Web of Science ®Google Scholar
• Guzmán MG, Kourí G.Dengue diagnosis, advances and challenges. Int J Infect Dis 2004;8: 69–80.
   PubMed Web of Science ®Google Scholar
• Priyamvada L, Quicke KM, Hudson WHet al.Human antibody responses after dengue virus infection are highly cross-reactive to Zika virus. Proc Natl Acad Sci USA 2016;113: 7852–7857.
   PubMed Web of Science ®Google Scholar
• Mansfield KL, Horton DL, Johnson Net al.Flavivirus-induced antibody cross-reactivity. J Gen Virol 2011;92: 2821–2829.
   PubMed Web of Science ®Google Scholar
• Koraka P, Zeller H, Niedrig Met al.Reactivity of serum samples from patients with a flavivirus infection measured by immunofluorescence assay and ELISA. Microbes Infect 2002;4: 1209–1215.
   PubMed Web of Science ®Google Scholar
• Sanchini A, Donoso-Mantke O, Papa Aet al.Second international diagnostic accuracy study for the serological detection of West Nile virus infection. PLoS Negl Trop Dis 2013;7: e2184.
   PubMed Web of Science ®Google Scholar
• Domingo C, Alves MJ, de Ory Fet al.International external quality control assessment for the serological diagnosis of dengue infections. BMC Infect Dis 2015;15: 1–8.
   PubMed Web of Science ®Google Scholar
• Felix AC, Souza NCS, Figueiredo WMet al.Cross reactivity of commercial anti-dengue immunoassays in patients with acute Zika virus infection. J Med Virol 2017;89: 1477–1479.
   PubMed Web of Science ®Google Scholar
• Maeda A, Maeda J.Review of diagnostic plaque reduction neutralization tests for flavivirus infection. Vet J 2013;195: 33–40.
   PubMed Web of Science ®Google Scholar
• Crill WD, Chang G-JJ.Localization and characterization of flavivirus envelope glycoprotein cross-reactive epitopes. J Virol 2004;78: 13975–13986.
   PubMed Web of Science ®Google Scholar
• Lai C-Y, Tsai W-Y, Lin S-Ret al.Antibodies to envelope glycoprotein of dengue virus during the natural course of infection are predominantly cross-reactive and recognize epitopes containing highly conserved residues at the fusion loop of domain II. J Virol 2008;82: 6631–6643.
   PubMed Web of Science ®Google Scholar
• Seligman SJ.Constancy and diversity in the flavivirus fusion peptide. Virol J 2008;5: 27.
   PubMed Web of Science ®Google Scholar
• Roberson JA, Crill WD, Chang G-JJ.Differentiation of West Nile and St. Louis encephalitis virus infections by use of noninfectious virus-like particles with reduced cross-reactivity. J Clin Microbiol 2007;45: 3167–3174.
   PubMed Web of Science ®Google Scholar
• Chiou S-S, Crill WD, Chen L-Ket al.Enzyme-linked immunosorbent assays using novel Japanese encephalitis virus antigen improve the accuracy of clinical diagnosis of flavivirus infections. Clin Vaccine Immunol 2008;15: 825–835.
   PubMedGoogle Scholar
• Vogt MR, Dowd KA, Engle Met al.Poorly neutralizing cross-reactive antibodies against the fusion loop of West Nile virus envelope protein protect in vivo via Fcgamma receptor and complement-dependent effector mechanisms. J Virol 2011;85: 11567–11580.
   PubMed Web of Science ®Google Scholar
• Chabierski S, Barzon L, Papa Aet al.Distinguishing West Nile virus infection using a recombinant envelope protein with mutations in the conserved fusion-loop. BMC Infect Dis 2014;14: 246.
   PubMed Web of Science ®Google Scholar
• Rockstroh A, Barzon L, Pacenti Met al.Recombinant envelope-proteins with mutations in the conserved fusion loop allow specific serological diagnosis of dengue-infections. PLoS Negl Trop Dis 2015;9: e0004218.
   PubMed Web of Science ®Google Scholar
• Crill WD, Trainor NB, Chang G-JJ.A detailed mutagenesis study of flavivirus cross-reactive epitopes using West Nile virus-like particles. J Gen Virol 2007;88: 1169–1174.
   PubMed Web of Science ®Google Scholar
• Gyurech D, Schilling J, Schmidt-Chanasit Jet al.False positive dengue NS1 antigen test in a traveller with an acute Zika virus infection imported into Switzerland. Swiss Med Wkly 2016;146: w14296.
   PubMed Web of Science ®Google Scholar
• van Meer MP, Mögling R, Klaasse Jet al.Re-evaluation of routine dengue virus serology in travelers in the era of Zika virus emergence. J Clin Virol 2017;92: 25–31.
   PubMed Web of Science ®Google Scholar
• Lustig Y, Zelena H, Venturi Get al.Sensitivity and kinetics of an NS1-based Zika virus enzyme-linked immunosorbent assay in Zika virus-infected travelers from Israel, the Czech Republic, Italy, Belgium, Germany, and Chile. J Clin Microbiol 2017;55: 1894–1901.
   PubMed Web of Science ®Google Scholar
• Huzly D, Hanselmann I, Schmidt-Chanasit Jet al.High specificity of a novel Zika virus ELISA in European patients after exposure to different flaviviruses. Euro Surveill 2016;21: 30203.
   Google Scholar
• L’Huillier AG, Hamid-Allie A, Kristjanson Eet al.Evaluation of euroimmun anti-zika virus igm and igg enzyme-linked immunosorbent assays for zika virus serologic testing. J Clin Microbiol 2017;55: 2462–2471.
   PubMed Web of Science ®Google Scholar
• Steinhagen K, Probst C, Radzimski Cet al.Serodiagnosis of Zika virus (ZIKV) infections by a novel NS1-based ELISA devoid of cross-reactivity with dengue virus antibodies: a multicohort study of assay performance, 2015 to 2016. Euro Surveill 2016;21: 30426.
   PubMedGoogle Scholar
• Hunsperger Ea, Yoksan S, Buchy Pet al.Evaluation of commercially available diagnostic tests for the detection of dengue virus ns1 antigen and anti-dengue virus IgM antibody. PLoS Negl Trop Dis 2014;8: e3171.
   PubMed Web of Science ®Google Scholar
• Alagarasu K.Introducing dengue vaccine: Implications for diagnosis in dengue vaccinated subjects. Vaccine 2016;34: 2759–2761.
   PubMed Web of Science ®Google Scholar
• Barba-Spaeth G, Dejnirattisai W, Rouvinski Aet al.Structural basis of potent Zika-dengue virus antibody cross-neutralization. Nature 2016;536: 48–53.
   PubMed Web of Science ®Google Scholar
• Van Esbroeck M, Meersman K, Michiels Jet al.Letter to the editor: specificity of Zika virus ELISA: interference with malaria. Euro Surveill 2016;21: 30237.
   Google Scholar
• Schwarz NG, Mertens E, Winter Det al.No serological evidence for Zika virus infection and low specificity for anti-Zika virus ELISA in malaria positive individuals among pregnant women from Madagascar in 2010. PLoS One 2017;12: e0176708.
   PubMed Web of Science ®Google Scholar
• Braga C, Luna CF, Martelli CMet al.Seroprevalence and risk factors for dengue infection in socio-economically distinct areas of Recife, Brazil. Acta Trop 2010;113: 234–240.
   PubMed Web of Science ®Google Scholar
• Dejnirattisai W, Supasa P, Wongwiwat Wet al.Dengue virus sero-cross-reactivity drives antibody-dependent enhancement of infection with zika virus. Nat Immunol 2016;17: 1102–1108.
   PubMed Web of Science ®Google Scholar
• Stettler K, Beltramello M, Espinosa DAet al.Specificity, cross-reactivity, and function of antibodies elicited by Zika virus infection. Science 2016;353: 823–826.
   PubMed Web of Science ®Google Scholar
• Bardina SV, Bunduc P, Tripathi Set al.Enhancement of Zika virus pathogenesis by preexisting antiflavivirus immunity. Science 2017;356: 175–180.
   PubMed Web of Science ®Google Scholar
• Corman VM, Rasche A, Baronti Cet al.Assay optimization for molecular detection of Zika virus. Bull World Heal Organ 2016;94: 879–892.
   Web of Science ®Google Scholar
• Zhang B, Pinsky BA, Ananta JSet al.Diagnosis of Zika virus infection on a nanotechnology platform. Nat Med 2017;23: 548–550.
   PubMed Web of Science ®Google Scholar
• Balmaseda A, Stettler K, Medialdea-Carrera Ret al.Antibody-based assay discriminates Zika virus infection from other flaviviruses. Proc Natl Acad Sci USA 2017;114: 8384–8389.
   PubMed Web of Science ®Google Scholar